Page last updated: 2024-08-23

paclitaxel and Antidiuretic Hormone, Inappropriate Secretion

paclitaxel has been researched along with Antidiuretic Hormone, Inappropriate Secretion in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Angelini, C; Arosio, P; Bertuzzi, A; Colombo, P; Cucchiari, D; De Sanctis, R; Faucher, E; Fusco, N; Pellegrinelli, A1
Markham, MJ; Murphy, MC1
Babai, S; Kempf, E; Le-Louët, H; Neuzillet, C; Pujol, G; Rousseau, B1
Fujioka, S; Haruki, T; Miwa, K; Nakamura, H; Takagi, Y; Taniguchi, Y; Yurugi, Y1
Futagami, M; Mizunuma, H; Shigeto, T; Yokoyama, Y1
Heilmann, M; Langer-Nitsche, C; Lück, HJ1

Other Studies

6 other study(ies) available for paclitaxel and Antidiuretic Hormone, Inappropriate Secretion

ArticleYear
Juxtaglomerular cell tumor: multicentric synchronous disease associated with paraneoplastic syndrome.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, May-10, Volume: 31, Issue:14

    Topics: Antidiuretic Hormone Receptor Antagonists; Antineoplastic Combined Chemotherapy Protocols; Benzazepines; Dacarbazine; Deoxycytidine; Diagnosis, Differential; Disease Progression; Doxorubicin; Gemcitabine; Humans; Hyponatremia; Ifosfamide; Immunohistochemistry; Immunophenotyping; Inappropriate ADH Syndrome; Juxtaglomerular Apparatus; Kidney Neoplasms; Luminescent Measurements; Male; Middle Aged; Neoplasms, Multiple Primary; Paclitaxel; Paraneoplastic Syndromes; Renin; Tolvaptan; Vinblastine; Vinorelbine

2013
Rare case of syndrome of inappropriate antidiuretic hormone as the initial presentation of ovarian cancer recurrence.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Mar-20, Volume: 33, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Female; Humans; Inappropriate ADH Syndrome; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Tomography, X-Ray Computed

2015
Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinoma.
    Medicine, 2016, Volume: 95, Issue:26

    Topics: Adenocarcinoma; Aged; Albumins; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Paclitaxel; Pancreatic Neoplasms; Severity of Illness Index

2016
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) following carboplatin-paclitaxel administration in a patient with lung cancer.
    Die Pharmazie, 2011, Volume: 66, Issue:9

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lung; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Paclitaxel; Vasopressins

2011
Syndrome of inappropriate secretion of anti-diuretic hormone following carboplatin-paclitaxel administration in a patient with recurrent ovarian cancer.
    European journal of gynaecological oncology, 2005, Volume: 26, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Diagnosis, Differential; Female; Humans; Inappropriate ADH Syndrome; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel

2005
Severe syndrome of inappropriate antidiuretic hormone secretion with docetaxel treatment in metastatic breast cancer.
    Acta oncologica (Stockholm, Sweden), 2000, Volume: 39, Issue:8

    Topics: Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Female; Humans; Inappropriate ADH Syndrome; Paclitaxel; Taxoids

2000